日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations

饱和诱变法可鉴定出激活和诱导耐药性的FGFR激酶结构域突变

Tangermann, Carla; Ghosh, Avantika; Ziegler, Martin; Facchinetti, Francesco; Stappenbeck, Jannis; Carus Sahin, Yagmur Oyku; Riester, Marisa; Viardot, Luise Carmina; Zundel, Tobias; Friboulet, Luc; Hollebecque, Antoine; Naveja, José J; Wanninger, Angela; Hess, Maria Elena; Brummer, Tilman; Boerries, Melanie; Loges, Sonja; Loriot, Yohann; Illert, Anna L; Diederichs, Sven

Current landscape and challenges of neuro-oncological molecular tumor boards in Germany: results of a nationwide follow-up survey

德国神经肿瘤分子肿瘤委员会的现状及挑战:一项全国性随访调查的结果

Hönikl, Lisa S; Lange, Sebastian; Meyer, Bernhard; Combs, Stephanie E; Lörsch, Alisa M; Illert, Anna Lena; Wagner, Arthur; Schmidt-Graf, Friederike

Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies

由STAT5激活癌基因诱导的抑癌素M促进血液系统恶性肿瘤的疾病进展。

Rassner, Michael; Müller, Tony Andreas; Crossley, Kirstyn Anne; Andrieux, Geoffroy; Schaberg, Sabina; Endres, Cornelia; Jakob, Lena; Poggio, Teresa; Köhler, Natalie; Kolter, Julia; Müller-Newen, Gerhard; Schönberger, Katharina; Cabezas-Wallscheid, Nina; Gonzalez-Menendez, Irene; Quintanilla-Martinez, Leticia; Zwick, Melissa; Ashok, Driti; Hartmann, Tanja Nicole; Groß, Olaf; Gorka, Oliver; Follo, Marie; Illert, Anna Lena; Boerries, Melanie; Zeiser, Robert; Duyster, Justus

Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling

JAK1/2抑制剂在小鼠骨髓增生性肿瘤中的疗效并非通过靶向致癌信号通路介导。

Gorantla, Sivahari Prasad; Rassner, Michael; Crossley, Kirstyn Anne; Müller, Tony Andreas; Poggio, Teresa; Khaja Saleem, Shifa; Kleinfelder, Helen; Gambheer, Sudheer Madan Mohan; Endres, Cornelia; Schaberg, Sabina; Schmidt, Dominik; Prince, Gerin; Gonzalez-Menendez, Irene; Bentrop, Detlef; Trittler, Rainer; Rylova, Svetlana; Pfeifer, Dietmar; Andrieux, Geoffroy; Quintanilla-Martinez, Leticia; Illert, Anna Lena; von Bubnoff, Nikolas; Zeiser, Robert; Duyster, Justus

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma

全面的基因组和转录组分析为腹膜和胸膜间皮瘤的分子靶向治疗提供了可能。

Möhrmann, L; Werner, M; Oleś, M; Knol, L; Arnold, J S; Mundt, T; Paramasivam, N; Richter, D; Fröhlich, M; Hutter, B; Hüllein, J; Jahn, A; Scheffold, C; Möhrmann, E E; Hanf, D; Kreutzfeldt, S; Heilig, C E; Teleanu, M-V; Lipka, D B; Beck, K; Baude-Müller, A; Jelas, I; Rieke, D T; Klotz, L V; Shah, R; Herold, T; Boerries, M; Illert, A L; Allgäuer, M; Stenzinger, A; Kerle, I A; Horak, P; Heining, C; Schröck, E; Hübschmann, D; Fröhling, S; Glimm, H

Modeling the t(2;5) Translocation of Anaplastic Large Cell Lymphoma Using CRISPR-Mediated Chromosomal Engineering

利用 CRISPR 介导的染色体工程技术模拟间变性大细胞淋巴瘤的 t(2;5) 易位

Khan, Robin; Phely, Laurent; Ehrenfeld, Sophia; Schmitz, Tatjana; Veratti, Pia; Wolfes, Jakob; Shoumariyeh, Khalid; Andrieux, Geoffroy; Martens, Uta S; Bra, Stephan de; Auer, Martina; Schilling, Oliver; Boerries, Melanie; Speicher, Michael; Illert, Anna L; Duyster, Justus; Miething, Cornelius

Lenvatinib after progression on pemigatinib and futibatinib in FGFR2 fusion-positive biliary tract cancer with an acquired kinase point mutation

在接受培米替尼和夫替巴替尼治疗后病情进展的FGFR2融合阳性胆道癌患者中,若存在获得性激酶点突变,则可使用乐伐替尼治疗。

Kleinhenz, Fabian; Pfarr, Nicole; Steinhelfer, Lisa; Lörsch, Alisa M; Bendz, Henriette; Friedrich, Mathias; Liesenfeld, Lea; Barroux, Melissa; Maurer, Carlo; Wenzel, Patrick; Kestler, Angelika; Koppermann, Mai-Lan; Mogler, Carolin; Spahn, Stephan; Illert, Anna L; Schmid, Roland M; Bitzer, Michael; Lange, Sebastian

Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma

肝脏FDG摄取增强了早期PET/CT对弥漫性大B细胞淋巴瘤CD19靶向CAR-T细胞疗法的预后价值

Beck, Michael; Blumenberg, Viktoria; Bücklein, Veit L; Bundschuh, Ralph A; Harrer, Dennis C; Hirschbühl, Klaus; Jung, Johannes; Kunz, Wolfgang G; Menhart, Karin; Winkelmann, Michael; Yakushev, Igor; Illert, Anna Lena; Eckstein, Markus; Völkl, Simon; Claus, Rainer; Hansmann, Leo; Hecker, Judith S; Kuwert, Torsten; Mackensen, Andreas; Subklewe, Marion; Hellwig, Dirk; Müller, Fabian

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

德国一项针对外分泌性胰腺癌患者的研究发现,17.6% 的患者被诊断患有遗传性肿瘤综合征——这是否意味着需要进行普遍的基因检测?

William, D; Bermúdez, M; Kübler, A; Kahlert, C; Distler, M; Weitz, J; Uhrig, S; Fröhlich, M; Hutter, B; Aust, D; Baretton, G; Wimberger, P; Kast, K; Meisel, C; Gieldon, L; Porrmann, J; Wagner, J; Arlt, M; Franke, M; Fischer, J; Hackmann, K; Kreutzfeldt, S; Mock, A; Heilig, C E; Lipka, D B; Teleanu, M-V; Schlenk, R F; Brors, B; Hübschmann, D; Paramasivam, N; Richter, D; Beck, K; Pfütze, K; Buchhalter, I; Weichert, W; Herold, T; Spiekermann, K; Jost, P J; Keilholz, U; Klauschen, F; Bauer, S; Siveke, J T; Kindler, T; Boerries, M; Illert, A L; Bitzer, M; Schulze-Osthoff, K; Schirmacher, P; Stenzinger, A; Horak, P; Heining, C; Folprecht, G; Fröhling, S; Glimm, H; Schröck, E; Jahn, A

The Technical University of Munich Cancer Center - elevating cancer treatment through science

慕尼黑工业大学癌症中心——通过科学提升癌症治疗水平

Hecker, Judith S; Algül, Hana; Illert, Anna L; Bassermann, Florian